It is a pharma private limited company based in Cuttack, Orissa, India, established in 2004.
2004 | Cuttack, Orissa, India | ActiveOro Pharmaceuticals Private Limited, a active private limited company, was established on 09 March 2004 in Cuttack, Orissa, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232OR2004PTC007517. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹6.00 M.
It upholds a compliant status. Employing 16 professional, Its leadership includes Akshaya Kumar Jena (Director), Namita Jena (Director), Saswat Anumeya Jena (Director). Past directors included Shanta Ray, Bishnu Charan Jena, Ramakanta Jena. It holds ₹3.99 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bahar Bisinabarlink Road, Cuttack, Orissa, 753012.
U24232OR2004PTC007517
007517
09 March 2004
₹6.00 M
₹6.00 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Oro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akshaya Kumar Jena | Director | 19 Feb 2024 | Current |
| Namita Jena | Director | 19 Feb 2024 | Current |
| Saswat Anumeya Jena | Director | 19 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Feb 2024 | Past |
| Pramod Abcsdd | Director | 19 Feb 2024 | Past |
| Pramod Abcsdd | Director | 07 Mar 2024 | Past |
| Pramod Abcsdd | Director | 19 Feb 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oro Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.25% decrease. The company also saw a substantial improvement in profitability, with a 15.23% increase in profit. The company's net worth Soared by an impressive increase of 22.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Oro Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹39,892,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2022 | Bank Of India | ₹2.34 M | Open |
| 27 Feb 2006 | Bank Of India | ₹3.76 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Oro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Bank Of India of Rs. 37.56 M registered on 27 Feb 2006 with Charge ID 80023395 was modified on 30 Dec 2024. was completed.
The activity Oro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Oro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack. was documented.
Akshaya Kumar Jena was appointed as a Director was appointed as a Director on 19 Feb 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
Progress on Namita Jena was appointed as a Director was appointed as a Director on 19 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
Progress on Saswat Anumeya Jena was appointed as a Director was appointed as a Director on 19 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
The CIN of Oro Pharmaceuticals Private Limited is U24232OR2004PTC007517.
Oro Pharmaceuticals Private Limited is headquartered at Bahar Bisinabarlink Road, Cuttack, Orissa, 753012.
Oro Pharmaceuticals Private Limited was incorporated on 09 March 2004.
The current directors of Oro Pharmaceuticals Private Limited are
The primary industry of Oro Pharmaceuticals Private Limited is Trade.
Oro Pharmaceuticals Private Limited is unlisted.
The authorized capital of Oro Pharmaceuticals Private Limited is ₹6.00 M, and the paid-up capital is ₹6.00 M.
The compliance status of Oro Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX